Researchers develop novel AI-based estimator for manufacturing medicine
A collaborative research team from the MIT-Takeda Program combined physics and machine learning to characterize rough particle surfaces in pharmaceutical pills and powders.
A collaborative research team from the MIT-Takeda Program combined physics and machine learning to characterize rough particle surfaces in pharmaceutical pills and powders.
MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.